Medigrowth Australia has named former Canopy Growth manager Dr Ashleigh Osborne as its national medical lead.
Osborne spent four-and-a-half years at Canopy, joining the medical science liaison team in NSW in April 2020 before rising to country medical affairs manager in October 2022.
The People’s Plant
A rush of support in the final hours of a Birchal crowdsource funding campaign saw The People’s Plant nudge past the A$1 million mark.
Epsilon Healthcare
The Deed of Company Arrangement (DOCA) for Epsilon Pharma and Epsilon Clinics has been completed, but management is continuing to “address matters” in relation to the parent company, Epsilon Healthcare, the company has said.
Byron Bay Bio
Byron Bay Bio has raised A$233,168 from 122 investors with one day of its Birchal crowdsource funding campaign to run.
Continue reading...
Last edited by a moderator:
